142 related articles for article (PubMed ID: 21996380)
1. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010.
Asensio A; Alvarez-Espejo T; Fernandez-Crehuet J; Ramos A; Vaque-Rafart J; Bishopberger C; Hernandez Navarrete M; Calbo-Torrecillas F; Campayo J; Canton R;
Euro Surveill; 2011 Oct; 16(40):. PubMed ID: 21996380
[No Abstract] [Full Text] [Related]
2. High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
Rohde AM; Wiese-Posselt M; Zweigner J; Schwab F; Mischnik A; Seifert H; Gastmeier P; Kern WV;
J Antimicrob Chemother; 2018 Jun; 73(6):1688-1691. PubMed ID: 29490046
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
4. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of third-generation cephalosporin resistance in Enterobacteriaceae from 2000 to 2008 in a Perpignan hospital].
Mayoral G; Ferreyra M; Eden A; Gueudet P; Miquel C; Lecaillon E
Pathol Biol (Paris); 2010 Feb; 58(1):7-10. PubMed ID: 19854588
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of antibiotic resistance of Enterobacteriaceae strains isolated in community- and hospital-acquired infections in teaching hospitals of Hamadan, west of Iran.
Hashemi SH; Esna-Ashari F; Tavakoli S; Mamani M
J Res Health Sci; 2013 May; 13(1):75-80. PubMed ID: 23772019
[TBL] [Abstract][Full Text] [Related]
8. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals.
von Baum H; Lin D; Wendt C
Clin Microbiol Infect; 2004 May; 10(5):436-40. PubMed ID: 15113322
[TBL] [Abstract][Full Text] [Related]
11. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of Enterobacteriaceae resistance to antibiotics in Reunion Island: emergence of extended-spectrum beta-lactamases].
Belmonte O; Drouet D; Alba J; Moiton MP; Kuli B; Lugagne-Delpon N; Mourlan C; Jaffar-Bandjee MC
Pathol Biol (Paris); 2010 Feb; 58(1):18-24. PubMed ID: 19864085
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae.
Wendt C; Lin D; von Baum H
Infection; 2005 Oct; 33(5-6):327-32. PubMed ID: 16258862
[TBL] [Abstract][Full Text] [Related]
17. Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S1-3. PubMed ID: 22749052
[No Abstract] [Full Text] [Related]
18. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
Livermore DM; Hope R; Reynolds R; Blackburn R; Johnson AP; Woodford N
J Antimicrob Chemother; 2013 Nov; 68(11):2667-74. PubMed ID: 23766490
[TBL] [Abstract][Full Text] [Related]
19. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
